Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | $249K | — | — | — |
| Gross profit | — | — | $48.9K | — | — | — |
| Gross margin | — | — | 19.6% | — | — | — |
| Operating income | -$1.20M | -$3.23M | -$9.32M | -$10.3M | -$7.17M | -$6.95M |
| Operating margin | — | — | -3741.5% | — | — | — |
| Net income | -$1.16M | -$3.49M | -$9.30M | -$9.95M | -$7.72M | -$6.85M |
| Net margin | — | — | -3733.1% | — | — | — |
| EPS (diluted) | -$0.37 | -$0.41 | -$9.22 | -$3,631.48 | -$456.75 | -$15.25 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$509K | -$4.37M | -$7.74M | -$8.31M | -$7.82M | -$6.05M |
| Capital expenditures | — | $23.9K | $1.20M | $704K | $307K | $174K |
| Free cash flow | — | -$4.39M | -$8.94M | -$9.02M | -$8.13M | -$6.23M |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $912K | $19.0M | $10.1M | $2.21M | $4.30M | $5.16M |
| Total assets | $1.52M | $21.0M | $13.5M | $4.87M | $6.66M | $7.12M |
| Total liabilities | $1.85M | $637K | $1.98M | $1.97M | $928K | $1.14M |
| Shareholders' equity | -$4.21M | $20.4M | $11.5M | $2.89M | $5.73M | $5.98M |
| Retained earnings | -$4.21M | -$7.69M | -$17.0M | -$27.0M | -$34.7M | -$41.5M |
| Shares (wtd avg diluted) | 3.15M | 8.52M | 1.01M | 2.74B | 45.8B | 449K |
Every figure is extracted from Bluejay Diagnostics, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.